Provided by Tiger Trade Technology Pte. Ltd.

Bioventus Inc.

13.85
-0.1700-1.21%
Volume:90.99K
Turnover:1.26M
Market Cap:1.16B
PE:17.71
High:14.02
Open:14.02
Low:13.69
Close:14.02
52wk High:15.89
52wk Low:6.26
Shares:84.09M
Float Shares:33.47M
Volume Ratio:0.74
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7821
EPS(LYR):0.3300
ROE:25.68%
ROA:5.49%
PB:5.10
PE(LYR):41.97

Loading ...

Bioventus Q2 FY26 GAAP EPS Rises to $0.47; Revenue Increases 4% to $153.2 Million

Reuters
·
Aug 05

Bioventus Q2 Adjusted Ebitda USD 35.3 Million

Reuters
·
Aug 05

Bioventus Inc.: Initiates Review of Strategic Alternatives

THOMSON REUTERS
·
Aug 05

Bioventus: Evaluating Range of Strategic Options, Including but not Limited to Sale, or Continued Execution of Co's Standalone Plan

THOMSON REUTERS
·
Aug 05

Bioventus Inc.: Reaffirms Revenue, Adjusted Diluted EPS* and Cash from Operations Guidance for Full Year 2026

THOMSON REUTERS
·
Aug 05

Bioventus - Makes $20 Mln Discretionary Principal Prepayment on Term Loan in Q2

THOMSON REUTERS
·
Aug 05

Press Release: Bioventus Reports Second Quarter Financial Results

Dow Jones
·
Aug 05

Bravura Sets Investor Briefing for FY26 Results Release

TIPRANKS
·
Aug 05

Bioventus Inc Expected to Post Earnings of 22 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Bioventus Sets Second-quarter Fiscal 2026 Results Release, Conference Call

Reuters
·
Jul 29

Bravura Secures Dual Listing with Admission to London’s AIM

TIPRANKS
·
Jul 28

Canaccord Genuity Reaffirms Their Buy Rating on Bravura Solutions Limited (BVS)

TIPRANKS
·
Jul 15

Bravura Solutions Limited (BVS) Receives a Hold from Macquarie

TIPRANKS
·
Jul 14

Bravura Solutions Limited (BVS) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Jul 13

Bravura Issues Notice on Conversion of Unquoted Equity Securities

TIPRANKS
·
Jul 10

Bioventus is Maintained at Outperform by Barrington Research

Dow Jones
·
Jun 30

Bravura Solutions Targets AIM Dual Listing to Boost Global Investor Reach

TIPRANKS
·
Jun 30

Bioventus management to meet with Barrington

TIPRANKS
·
Jun 17

Bioventus Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jun 16

Bioventus Buy Rating Reiterated on Strengthening Fundamentals and Growth Pillars; $15 Price Target Maintained

TIPRANKS
·
Jun 16